APO RESEARCH · REPORT
Organoids
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Product & engineering
Understand the product.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
Selected research
Industry Research
Organoids Industry Research Report 2026
Market perspective
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality. Organoids address the limitations of existing model systems by providing:
Similar composition and architecture to primary tissue: Organoids harbor small population of self-renewing stem cells that can differentiate into cells of all major cell lineages, with similar frequency as in physiological condition.
Relevant models of in-vivo conditions: Organoids are more biologically relevant to any model system and are amenable to manipulate niche components and gene sequence.
Read the full market overview
Stable system for extended cultivation: Organoids can be cryopreserved as biobanks and expanded indefinitely by leveraging self-renewal, differentiation capability of stem cell and intrinsic ability to self-organize.
From perspective of type, organoids can be split into 3D Organoid Culture, Biochemical Cues and others. In 2018, D3D Organoid Culture took accounted for nearly 71%, which made it the largest segment of global organoids.
North America is the largest consumption region of organoids, with a consumption market share nearly 46% in 2019. The second place is Europe; following North America with the consumption market share over 40% in 2019.
Key manufacturers of global organoids market are Thermo Fisher Scientific, Merck and Corning. The top 3 players totally took up a market share of about 75% in 2019. Thermo Fisher Scientific is in the first place, which accounted for above 34% of global market.
Report Scope
This report quantifies the global Organoids market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Organoids.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Organoids Market by Company
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Cellesce
DefiniGEN
OcellO B.V.
HUB Oranoid Technology
3Dnamics Inc.
Organoid Therapeutics
InSphero
Organoids Segment by Type
3D Organoid Culture
Biochemical Cues
Organoids Segment by Application
Biopharmaceutical Companies
Contract Research Organizations
Academics and Research Institutes
Organoids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organoids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organoids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Organoids companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 3D Organoid Culture
- Biochemical Cues
Applications
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
Companies covered
- Thermo Fisher Scientific
- Merck
- Corning
- STEMCELL Technologies
- Lonza
- Prellis Biologics
- amsbio
- Cellesce
- DefiniGEN
- OcellO B.V.
- HUB Oranoid Technology
- 3Dnamics Inc.
- Organoid Therapeutics
- InSphero
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Organoids by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 3D Organoid Culture
- 2.2.3 Biochemical Cues
- 2.3 Organoids by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Contract Research Organizations
- 2.3.4 Academics and Research Institutes
- 2.4 Assumptions and Limitations
3 Organoids Breakdown Data by Type
- 3.1 Global Organoids Historic Market Size by Type (2021-2026)
- 3.2 Global Organoids Forecasted Market Size by Type (2027-2032)
4 Organoids Breakdown Data by Application
- 4.1 Global Organoids Historic Market Size by Application (2021-2026)
- 4.2 Global Organoids Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Organoids Market Perspective (2021-2032)
- 5.2 Global Organoids Growth Trends by Region
- 5.2.1 Global Organoids Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Organoids Historic Market Size by Region (2021-2026)
- 5.2.3 Organoids Forecasted Market Size by Region (2027-2032)
- 5.3 Organoids Market Dynamics
- 5.3.1 Organoids Industry Trends
- 5.3.2 Organoids Market Drivers
- 5.3.3 Organoids Market Challenges
- 5.3.4 Organoids Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Organoids Players by Revenue
- 6.1.1 Global Top Organoids Players by Revenue (2021-2026)
- 6.1.2 Global Organoids Revenue Market Share by Players (2021-2026)
- 6.2 Global Organoids Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Organoids Head Office and Area Served
- 6.4 Global Organoids Players, Product Type & Application
- 6.5 Global Organoids Manufacturers Established Date
- 6.6 Global Organoids Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Organoids Market Size (2021-2032)
- 7.2 North America Organoids Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Organoids Market Size by Country (2021-2026)
- 7.4 North America Organoids Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Organoids Market Size (2021-2032)
- 8.2 Europe Organoids Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Organoids Market Size by Country (2021-2026)
- 8.4 Europe Organoids Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Organoids Market Size (2021-2032)
- 9.2 Asia-Pacific Organoids Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Organoids Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Organoids Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Organoids Market Size (2021-2032)
- 10.2 South America Organoids Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Organoids Market Size by Country (2021-2026)
- 10.4 South America Organoids Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Organoids Market Size (2021-2032)
- 11.2 Middle East & Africa Organoids Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Organoids Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Organoids Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Organoids Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Organoids Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Merck
- 12.2.1 Merck Company Information
- 12.2.2 Merck Business Overview
- 12.2.3 Merck Revenue in Organoids Business (2021-2026)
- 12.2.4 Merck Organoids Product Portfolio
- 12.2.5 Merck Recent Developments
- 12.3 Corning
- 12.3.1 Corning Company Information
- 12.3.2 Corning Business Overview
- 12.3.3 Corning Revenue in Organoids Business (2021-2026)
- 12.3.4 Corning Organoids Product Portfolio
- 12.3.5 Corning Recent Developments
- 12.4 STEMCELL Technologies
- 12.4.1 STEMCELL Technologies Company Information
- 12.4.2 STEMCELL Technologies Business Overview
- 12.4.3 STEMCELL Technologies Revenue in Organoids Business (2021-2026)
- 12.4.4 STEMCELL Technologies Organoids Product Portfolio
- 12.4.5 STEMCELL Technologies Recent Developments
- 12.5 Lonza
- 12.5.1 Lonza Company Information
- 12.5.2 Lonza Business Overview
- 12.5.3 Lonza Revenue in Organoids Business (2021-2026)
- 12.5.4 Lonza Organoids Product Portfolio
- 12.5.5 Lonza Recent Developments
- 12.6 Prellis Biologics
- 12.6.1 Prellis Biologics Company Information
- 12.6.2 Prellis Biologics Business Overview
- 12.6.3 Prellis Biologics Revenue in Organoids Business (2021-2026)
- 12.6.4 Prellis Biologics Organoids Product Portfolio
- 12.6.5 Prellis Biologics Recent Developments
- 12.7 amsbio
- 12.7.1 amsbio Company Information
- 12.7.2 amsbio Business Overview
- 12.7.3 amsbio Revenue in Organoids Business (2021-2026)
- 12.7.4 amsbio Organoids Product Portfolio
- 12.7.5 amsbio Recent Developments
- 12.8 Cellesce
- 12.8.1 Cellesce Company Information
- 12.8.2 Cellesce Business Overview
- 12.8.3 Cellesce Revenue in Organoids Business (2021-2026)
- 12.8.4 Cellesce Organoids Product Portfolio
- 12.8.5 Cellesce Recent Developments
- 12.9 DefiniGEN
- 12.9.1 DefiniGEN Company Information
- 12.9.2 DefiniGEN Business Overview
- 12.9.3 DefiniGEN Revenue in Organoids Business (2021-2026)
- 12.9.4 DefiniGEN Organoids Product Portfolio
- 12.9.5 DefiniGEN Recent Developments
- 12.10 OcellO B.V.
- 12.10.1 OcellO B.V. Company Information
- 12.10.2 OcellO B.V. Business Overview
- 12.10.3 OcellO B.V. Revenue in Organoids Business (2021-2026)
- 12.10.4 OcellO B.V. Organoids Product Portfolio
- 12.10.5 OcellO B.V. Recent Developments
- 12.11 HUB Oranoid Technology
- 12.11.1 HUB Oranoid Technology Company Information
- 12.11.2 HUB Oranoid Technology Business Overview
- 12.11.3 HUB Oranoid Technology Revenue in Organoids Business (2021-2026)
- 12.11.4 HUB Oranoid Technology Organoids Product Portfolio
- 12.11.5 HUB Oranoid Technology Recent Developments
- 12.12 3Dnamics Inc.
- 12.12.1 3Dnamics Inc. Company Information
- 12.12.2 3Dnamics Inc. Business Overview
- 12.12.3 3Dnamics Inc. Revenue in Organoids Business (2021-2026)
- 12.12.4 3Dnamics Inc. Organoids Product Portfolio
- 12.12.5 3Dnamics Inc. Recent Developments
- 12.13 Organoid Therapeutics
- 12.13.1 Organoid Therapeutics Company Information
- 12.13.2 Organoid Therapeutics Business Overview
- 12.13.3 Organoid Therapeutics Revenue in Organoids Business (2021-2026)
- 12.13.4 Organoid Therapeutics Organoids Product Portfolio
- 12.13.5 Organoid Therapeutics Recent Developments
- 12.14 InSphero
- 12.14.1 InSphero Company Information
- 12.14.2 InSphero Business Overview
- 12.14.3 InSphero Revenue in Organoids Business (2021-2026)
- 12.14.4 InSphero Organoids Product Portfolio
- 12.14.5 InSphero Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst